首页 › 基金 › Lunate Capital Ltd › NMRA

Lunate Capital Ltd 对 NMRA 的持仓历史

NEUMORA THERAPEUTICS INC. · 医疗保健

Lunate Capital Ltd 在 Q3 2026 的 13F 申报中披露持有 NMRA(NEUMORA THERAPEUTICS INC.)2,124,143 股,市值约 US$1.3M,约占其申报组合的 0.18%,在其申报持仓中市值排名第 13 位。 Lunate Capital Ltd 最近 7 个申报季度中有 7 个季度披露了 NMRA 持仓,最早可追溯至 Q1 2025。

最新持仓 (Q3 2026)2.12M 股
申报持仓市值$1.27M
组合权重0.18%
首次申报Q1 2025
最近变动持有
更新于2026-11-05

最后更新: 2026-11-05 · 来源: SEC EDGAR Form 13F-HR

Lunate Capital Ltd 对 NMRA 的持仓演变

Lunate Capital Ltd 于 Q1 2025 首次披露 NMRA 持仓:2,124,143 股(约 US$2.1M)。 该持仓在 Q1 2026 达到峰值 2,124,143 股,市值约 US$4.1M。 在 7 次申报中,Lunate Capital Ltd 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 2,124,143 股、市值约 US$1.3M。

逐季持仓明细

季度股数金额变化
Q1 2025 2.12M $2.12M 新进
Q2 2025 2.12M $1.56M 持有
Q3 2025 2.12M $3.87M 持有
Q4 2025 2.12M $3.80M 持有
Q1 2026 2.12M $4.14M 持有
Q2 2026 2.12M $3.61M 持有
Q3 2026 2.12M $1.27M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 NMRA 与 13F 数据

NMRA(NEUMORA THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 22 只申报持有 NMRA,申报仓位最大的包括:SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (US$5.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NMRA 的基金

查看 NMRA 的全部基金持有人 →

常见问题

How long has Lunate Capital Ltd held NMRA?

Lunate Capital Ltd has disclosed NMRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Lunate Capital Ltd's current position in NMRA?

As of Q3 2026, Lunate Capital Ltd holds 2.12M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $1.27M, representing 0.18% of its reported portfolio and ranking #13.

Has Lunate Capital Ltd been buying or selling NMRA?

In the latest 13F filing (Q3 2026), Lunate Capital Ltd held unchanged its position in NMRA. The position peaked in Q1 2026 at 2.12M shares.

Which other funds hold NMRA?

Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.